| 000 | 01667 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515002220.0 | ||
| 264 | 0 | _c20051230 | |
| 008 | 200512s 0 0 eng d | ||
| 022 | _a0300-2977 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNetea, M G | |
| 245 | 0 | 0 |
_aNOD2 3020insC mutation and the pathogenesis of Crohn's disease: impaired IL-1beta production points to a loss-of-function phenotype. _h[electronic resource] |
| 260 |
_bThe Netherlands journal of medicine _cSep 2005 |
||
| 300 |
_a305-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylmuramyl-Alanyl-Isoglutamine _xadministration & dosage |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCrohn Disease _xgenetics |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aHomozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-1 _xbiosynthesis |
| 650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _xgenetics |
| 650 | 0 | 4 |
_aLeukocytes, Mononuclear _ximmunology |
| 650 | 0 | 4 | _aLipopeptides |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aNod2 Signaling Adaptor Protein |
| 650 | 0 | 4 |
_aOligopeptides _xadministration & dosage |
| 650 | 0 | 4 |
_aPeptidoglycan _xadministration & dosage |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_aSignal Transduction _xgenetics |
| 650 | 0 | 4 |
_aToll-Like Receptor 2 _xgenetics |
| 700 | 1 | _aFerwerda, G | |
| 700 | 1 | _ade Jong, D J | |
| 700 | 1 | _aGirardin, S E | |
| 700 | 1 | _aKullberg, B J | |
| 700 | 1 | _avan der Meer, J W M | |
| 773 | 0 |
_tThe Netherlands journal of medicine _gvol. 63 _gno. 8 _gp. 305-8 |
|
| 999 |
_c15818005 _d15818005 |
||